Prof. Heinz Drexel, MD, FESC, Chairperson Prof. Alexander Niessner, MD, MSc, FESC Vice-Chairperson EuroCVP is organised by the ESC Working Group on Cardiovascular Pharmacotherapy with the ...
CHU de Nancy Institut Lorrain du Coeur et des Vaisseaux Vandoeuvre les Nancy, France Host Prof. Mitja Lainscak, FESC General Hospital Murska Sobota Department of Internal Medicine Murska Sobota, ...
The real incidence of ventricular arrhythmias in patients with CRT and complex pharmacological therapy of heart failure.
Effect of cardiac resynchronization therapy on ventricular tachycardias in patients with dilated cardiomyopathy and severe heart failure
Optimal therapy of heart failure in patients with atrial fibrillation
Optimal therapy of atrial fibrillation in patients with heart failure - Role of risk factor management and upstream therapies
Atrial remodeling in heart failure with and without preserved ejection fraction
Atrial fibrillation and heart failure - Current knowledge
Usefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure with preserved ejection fraction
Conclusion & take home message - Treating heart failure (HF) with device therapies : what's new? .